Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
GYRO
Upturn stock ratingUpturn stock rating

Gyrodyne Company of America Inc (GYRO)

Upturn stock ratingUpturn stock rating
$10.36
Last Close (24-hour delay)
Profit since last BUY-2.72%
upturn advisory
Consider higher Upturn Star rating
BUY since 8 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

08/14/2025: GYRO (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

0 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

Analysis of Past Performance

Type Stock
Historic Profit -100%
Avg. Invested days 13
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 08/14/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 18.19M USD
Price to earnings Ratio 45.94
1Y Target Price -
Price to earnings Ratio 45.94
1Y Target Price -
Volume (30-day avg) -
Beta 0.36
52 Weeks Range 6.80 - 11.96
Updated Date 06/29/2025
52 Weeks Range 6.80 - 11.96
Updated Date 06/29/2025
Dividends yield (FY) -
Basic EPS (TTM) 0.18

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -137.05%
Operating Margin (TTM) -121.3%

Management Effectiveness

Return on Assets (TTM) -
Return on Equity (TTM) -

Valuation

Trailing PE 45.94
Forward PE -
Enterprise Value 12400998
Price to Sales(TTM) 6.64
Enterprise Value 12400998
Price to Sales(TTM) 6.64
Enterprise Value to Revenue 2.59
Enterprise Value to EBITDA -8.07
Shares Outstanding 2199310
Shares Floating 662432
Shares Outstanding 2199310
Shares Floating 662432
Percent Insiders 31.95
Percent Institutions 36.97

ai summary icon Upturn AI SWOT

Gyrodyne Company of America Inc

stock logo

Company Overview

overview logo History and Background

Gyrodyne Company of America Inc. was founded in 1946, initially focusing on rotary-wing aircraft. Over time, it shifted its primary business to real estate development and management, particularly medical office properties.

business area logo Core Business Areas

  • Real Estate Operations: The primary business is the ownership, lease, and management of income-producing properties, mainly medical office buildings leased to physicians and medical-related tenants.

leadership logo Leadership and Structure

Gyrodyne's leadership consists of a board of directors and executive management team. The company structure reflects its focus on real estate management and investment.

Top Products and Market Share

overview logo Key Offerings

  • Medical Office Space: Gyrodyne's core offering is medical office space. Market share data is difficult to specify as this is a local business and data is limited, but Gyrodyne owns property in New York and other key areas. Competitors are other real estate investment trusts (REITs) and private landlords.

Market Dynamics

industry overview logo Industry Overview

The medical office building (MOB) market is driven by an aging population and increasing demand for outpatient healthcare services. It's characterized by stable occupancy rates and rental growth.

Positioning

Gyrodyne is a smaller player in the medical office building market, focusing on select properties and long-term leases with medical professionals. Competitive advantage may come from specializing in medical spaces and geographic location.

Total Addressable Market (TAM)

The US medical office building market is estimated at hundreds of billions of dollars. Gyrodyne's is positioned as a small player in a specialized market.

Upturn SWOT Analysis

Strengths

  • Stable revenue from long-term leases
  • Specialization in medical office space
  • Geographic concentration in high-demand areas (historically)
  • Relatively stable, low-risk business model

Weaknesses

  • Limited scale compared to larger REITs
  • Concentration risk in geographic area.
  • Dependence on healthcare industry trends
  • Lack of diversification

Opportunities

  • Acquisition of additional medical office properties
  • Expansion into new geographic markets
  • Development of new medical office buildings
  • Increase rental rates in existing properties

Threats

  • Economic downturn affecting healthcare spending
  • Increased competition from larger REITs
  • Changes in healthcare regulations
  • Rising interest rates affecting property values

Competitors and Market Share

competitor logo Key Competitors

  • DOC
  • HR
  • WELL
  • OHI

Competitive Landscape

Gyrodyne is a relatively small player compared to publicly traded REITs like Welltower (WELL) or Healthpeak Properties (DOC). It likely competes on a local or regional level, emphasizing personalized service and specialized medical office spaces. Bigger competitors have greater access to capital and a more diversified portfolio.

Growth Trajectory and Initiatives

Historical Growth: Requires financial data. As a real estate company, growth would be tied to property acquisitions and rental income.

Future Projections: Requires financial data and analyst estimates

Recent Initiatives: Recent initiatives would relate to property acquisitions, lease renewals, or property improvements. Requires further data and research.

Summary

Gyrodyne Company of America is a small real estate company specializing in medical office properties. Its stable revenue from long-term leases and specialization in the healthcare sector are strengths. However, its limited scale and geographic concentration pose challenges, with competition from larger REITs.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Publicly available information, including company websites, press releases, and industry reports. Limited access to private financials.
  • Company Filings
  • Industry Analysis Reports

Disclaimers:

This analysis is based on publicly available information and may not be entirely accurate due to limited data access. The AI-based rating is an estimate and should not be considered investment advice. Investment decisions should be based on thorough research and consultation with a financial advisor.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Gyrodyne Company of America Inc

Exchange NASDAQ
Headquaters Saint James, NY, United States
IPO Launch date 1995-08-18
President, CEO, CFO & Treasurer Mr. Gary Jay Fitlin
Sector Real Estate
Industry Real Estate Services
Full time employees 6
Full time employees 6

Gyrodyne, LLC (the "Company") owns and manages a diversified portfolio of real estate properties comprising office, industrial and service-oriented properties in the New York metropolitan area. The Company owns a 63-acre site approximately 50 miles east of New York City on the north shore of Long Island, which includes industrial and office buildings and undeveloped property, and a medical office park in Cortlandt Manor, New York, both of which are the subject of plans to seek value-enhancing entitlements. The Company's common shares are traded on the NASDAQ Capital Market under the symbol GYRO.